ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
131.065,44
-1,55%
S&P 500
5.702,55
-0,19%
US Dollar vs BRL
5,5146
1,64%
Bitcoin
63.142,38
0,31%
Brent Oil
74,135
-0,25%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. MannKind Corporation (MNKD)

  7. MannKind Corporation (MNKD) Notícias

MNKD

MannKind (MNKD)

MannKind Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MNKD
DataHoraFonteTítuloCódigoCompanhia
18/09/202407:15GlobeNewswire Inc.MannKind Announces Clearance from PMDA to Initiate Phase 3 Clinical Trial (ICoN-1) in Japan Evaluating Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:MNKDMannKind Corporation
10/09/202417:30GlobeNewswire Inc.MannKind to Present at 2024 Cantor Fitzgerald Global Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
04/09/202422:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MNKDMannKind Corporation
03/09/202417:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MNKDMannKind Corporation
27/08/202417:30GlobeNewswire Inc.MannKind to Present at Upcoming ConferencesNASDAQ:MNKDMannKind Corporation
14/08/202409:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MNKDMannKind Corporation
14/08/202409:00GlobeNewswire Inc.Kent Kresa to Retire from MannKind’s Board of Directors; Steven B. Binder to be Appointed to the BoardNASDAQ:MNKDMannKind Corporation
07/08/202409:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MNKDMannKind Corporation
07/08/202409:00GlobeNewswire Inc.MannKind Corporation Reports 2024 Second Quarter Financial Results: Provides Clinical Development UpdateNASDAQ:MNKDMannKind Corporation
07/08/202406:49IH Market NewsUS Index Futures Rise Amid Earnings Season Optimism, Oil Prices ReboundNASDAQ:MNKDMannKind Corporation
31/07/202407:30GlobeNewswire Inc.MannKind Launches Educational Website to Raise Awareness of NTM Lung DiseaseNASDAQ:MNKDMannKind Corporation
30/07/202417:30GlobeNewswire Inc.MannKind Corporation to Hold 2024 Second Quarter Financial Results Conference Call on August 7, 2024NASDAQ:MNKDMannKind Corporation
22/06/202409:00GlobeNewswire Inc.INHALE-3 Study Reveals Positive Readout in Head-to-Head Comparison of Inhaled Insulin vs. Usual Care in T1D; New Data Presented at American Diabetes Association’s 84th Scientific SessionsNASDAQ:MNKDMannKind Corporation
05/06/202407:45GlobeNewswire Inc.Inhale-3 Study Results to be Presented During a 90-Minute Symposium on Saturday, June 22 at the American Diabetes Association’s 84th Scientific SessionsNASDAQ:MNKDMannKind Corporation
29/05/202409:45GlobeNewswire Inc.MannKind to Establish Boston-Area Research & Development Foothold and Expand Portfolio of Dry Powder Inhalation Technology in Transaction With PulmatrixNASDAQ:MNKDMannKind Corporation
08/05/202417:18GlobeNewswire Inc.MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development UpdateNASDAQ:MNKDMannKind Corporation
06/05/202407:05GlobeNewswire Inc.MannKind Receives U.S. FDA Fast Track Designation for Clofazimine Inhalation Suspension for the Treatment of Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:MNKDMannKind Corporation
01/05/202417:00GlobeNewswire Inc.MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024NASDAQ:MNKDMannKind Corporation
30/04/202407:05GlobeNewswire Inc.MannKind to Proceed With Phase 1 Nintedanib Dpi (Mnkd-201) Study for Pulmonary Fibrotic DiseasesNASDAQ:MNKDMannKind Corporation
29/04/202407:05GlobeNewswire Inc.MannKind Announces IND Clearance From U.S. FDA to Start Phase 3 Study of Clofazimine Inhalation Suspension for Nontuberculous Mycobacterial (NTM) Lung DiseaseNASDAQ:MNKDMannKind Corporation
03/04/202407:00GlobeNewswire Inc.MannKind Repays Certain Debt ObligationsNASDAQ:MNKDMannKind Corporation
26/03/202417:05GlobeNewswire Inc.MannKind Announces CFO TransitionNASDAQ:MNKDMannKind Corporation
11/03/202407:05GlobeNewswire Inc.INHALE-3 Study’s Initial Meal Challenge Results Comparing Afrezza® Head-To-Head With Multiple Daily Injections (MDI) and Insulin PumpsNASDAQ:MNKDMannKind Corporation
05/03/202408:05GlobeNewswire Inc.MannKind Announces New Clinical Data From Inhale-3 Study to be Presented by Dr. Irl B. Hirsch at ATTD on March 8NASDAQ:MNKDMannKind Corporation
04/03/202415:01GlobeNewswire Inc.MannKind Corporation Announces Participation at Upcoming ConferencesNASDAQ:MNKDMannKind Corporation
27/02/202418:00GlobeNewswire Inc.MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development UpdateNASDAQ:MNKDMannKind Corporation
20/02/202408:00GlobeNewswire Inc.MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024NASDAQ:MNKDMannKind Corporation
15/02/202408:05GlobeNewswire Inc.MannKind Announces Enrollment Goal Completion of INHALE-1 Pediatric Diabetes Trial Utilizing Afrezza®NASDAQ:MNKDMannKind Corporation
02/01/202408:05GlobeNewswire Inc.MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 MillionNASDAQ:MNKDMannKind Corporation
28/12/202308:00GlobeNewswire Inc.MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:MNKD

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
HAGA3
HAGA ON
BOV
JFEN3
JOAO FORTES ON
BOV
AZEV4
AZEVEDO PN
BOV
COGN3
COGNA ON
BOV
AGXY3
Agrogalaxy Participacoes ON
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
BOV
GFSA3
GAFISA ON
BOV
AZEV3
AZEVEDO ON
BOV
RRRP3
3R Petroleum Oleo E Gas ... ON
BOV
RCSL4
RECRUSUL PN
BOV
VVEO3
CM Hospitalar ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
TELB4
TELEBRAS PN
BOV
CVCB3
CVC BRASIL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados